Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia. British journal of haematology [Br J Haematol] Journal article

Title	Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia.
Author(s)	Anoop P, Wotherspoon A, Matutes E
Institution	Department of Haematology, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, London, UK.
Source	Br J Haematol 2009 Oct 28.
Language	ENG
Pub Type(s)	JOURNAL ARTICLE
PubMed ID	19874308

Advertise on this site.